Sciwind rakes in $37m Series B

Sciwind, a developer of biologics, has secured $37 million in Series B financing.

Sciwind, a developer of biologics, has secured $37 million in Series B financing. LYFE Capital led the round with participation from Legend Capital and Haibang Venture Capital.

Source: Press Release